Rating: Strong Buy
Bristol-Myers Squibb Financial Health
Profitability:3.07/10
❌ Bristol-Myers Squibb has worst Profitability than 66.67% of the companies on the Drug Manufacturers industry
Net Margin: -0.11%
❌ Bristol-Myers Squibb has worst Net Margin than 66.67% of the companies on the Drug Manufacturers industry
ROE (Return on Equity): -0.02%
❌ Bristol-Myers Squibb has worst ROE (Return on Equity) than 60% of the companies on the Drug Manufacturers industry
ROA (Return on Assets): -0.01%
❌ Bristol-Myers Squibb has worst ROA (Return on Assets) than 66.67% of the companies on the Drug Manufacturers industry
Operating Efficiency:9.7/10
✅ Bristol-Myers Squibb has better Operating Efficiency than 75% of the companies on the Drug Manufacturers industry
Operating Margin: 50.55%
✅ Bristol-Myers Squibb has better Operating Margin than 75% of the companies on the Drug Manufacturers industry
Liquidity:6.44/10
✅ Bristol-Myers Squibb has better Liquidity than 83.33% of the companies on the Drug Manufacturers industry
Quick Ratio: 1.58
✅ Bristol-Myers Squibb has better Quick Ratio than 75% of the companies on the Drug Manufacturers industry
Operating Cash Flow Ratio: 0.61
✅ Bristol-Myers Squibb has better Operating Cash Flow Ratio than 58.33% of the companies on the Drug Manufacturers industry
Solvency:4.89/10
❌ Bristol-Myers Squibb has worst Solvency than 58.33% of the companies on the Drug Manufacturers industry
Debt to Equity Ratio: 0.91
❌ Bristol-Myers Squibb has worst Debt to Equity Ratio than 50% of the companies on the Drug Manufacturers industry
Interest Coverage Ratio: 0.61
✅ Bristol-Myers Squibb has better Interest Coverage Ratio than 58.33% of the companies on the Drug Manufacturers industry